Abstract:BACKGROUND: Uridine diphosphate-N-acetylglucosamine pyrophosphorylase-1-like-1 (UAP1L1) is involved in protein glycosylation and promotes proliferation in some tumors. By analyzing the publicly available Gene Expression Omnibus (GEO) database, we found that UAP1L1 displayed a significant change between paired glioma and normal brain tissues. The purpose of this study was to investigate the expression and functional role of UAP1L1 in glioma.METHODS: To determine the expression level of UAP1L1 in glioma, immunohistochemistry (IHC) staining was performed in tissue microarrays of 160 gliomas and 24 normal brain tissues. The correlation between UAP1L1 expression and the outcomes of glioma patients was analyzed. Human glioblastoma cell lines, U251 and U87, were employed in this study. Endogenous UAP1L1 expression in U251 and U87 cells was detected by quantitative real-time polymerase chain reaction (qRT-PCR). A lentiviral short hairpin RNA (shRNA) vector (shUAP1L1) was constructed and used to infect U251 and U87 cells to knock down the expression of UAP1L1. We performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, colony formation assay, flow cytometry, human apoptosis antibody array, and in vivo subcutaneous xenograft model to investigate the biological functions of UAP1L1.RESULTS: We revealed that UAP1L1 expression was obviously upregulated in the glioma tissues. The increased UAP1L1 expression level was clinically associated with higher tumor grades and poorer patient prognoses. Moreover, we demonstrated that UAP1L1 knockdown suppressed proliferation and increased apoptosis of glioma cells in vitro. In the xenograft mouse model, we further verified that UAP1L1 knockdown could attenuate the growth of glioma cells in vivo.CONCLUSIONS: These results indicated that UAP1L1 may play an oncogene-like role in glioma, especially in high grade glioma, and thus may be of clinical importance as a future therapeutic target.

<i>N</i>-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1

Hmga2 Sustains Self-Renewal and Invasiveness of Glioma-Initiating Cells

Greasy GLUT1 Maintains Glioblastoma Malignancy

C1GALT1 high expression enhances the progression of glioblastoma through the EGFR-AKT/ERK cascade

β1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLCγ-PKC pathways

Role of glycosylation-related gene MGAT1 in pancreatic ductal adenocarcinoma

Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.

High expression of β3GnT8 is associated with the metastatic potential of human glioma

N-acetylglucosaminyltransferase V drives colorectal cancer metastasis by facilitating ZO-1 ubiquitination and degradation

N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.

O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

Elevated α-1,2-mannosidase MAN1C1 in glioma stem cells and its implications for immunological changes and prognosis in glioma patients

C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells

UAP1L1 plays an oncogene-like role in glioma through promoting proliferation and inhibiting apoptosis

β1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma

Beta1,4-galactosyltransferase V A growth regulator in glioma.

N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance

Over-expression of ?-1,4-galactosyltransferase I, II, and V in Human Astrocytoma

Glucose regulates the HMGB1 signaling pathway through SIRT1 in glioma

High expression of immunity-related GTPase family M protein in glioma promotes cell proliferation and autophagy protein expression

Monocarboxylate transporter dependent mechanism is involved in proliferation, migration, and invasion of human glioblastoma cell lines via activation of PI3K/Akt signaling pathway